There’s a health threat killing thousands of people worldwide and getting worse. Researchers, including here in Boston, are working diligently to come up with new medications to stop it. It’s not the coronavirus. It's the rise of so-called “super-bugs.”
Each year, in the the U.S. alone, they cause 2.8 million infections and 48,000 deaths.
Unlike the novel coronavirus, doctors have seen the antibiotic resistance crisis coming for years and scientists have responded. In the last ten years, 16 new antibiotics won Food and Drug Administration approval. The problem — there’s no money in antibiotics.